CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CENPU | Centromere protein U | | | | | | Tissue enhanced |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CKAP2L | Cytoskeleton associated protein 2-like | | | | | | Tissue enhanced |
CLC | Charcot-Leyden crystal galectin | | | | | | Tissue enhanced |
CLEC12A | C-type lectin domain family 12, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4A | C-type lectin domain family 4, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4D | C-type lectin domain family 4, member D | Predicted membrane proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CTD-2207O23.3 | Rho guanine nucleotide exchange factor 18 | | | | | | Tissue enhanced |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CTSW | Cathepsin W | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL5 | Chemokine (C-X-C motif) ligand 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA4 | Defensin, alpha 4, corticostatin | Predicted secreted proteins
| | | | | Tissue enriched |
DNTT | DNA nucleotidylexotransferase | Enzymes Plasma proteins
| | | | | Tissue enriched |
DPPA4 | Developmental pluripotency associated 4 | | | | | | Tissue enhanced |
DTL | Denticleless E3 ubiquitin protein ligase homolog (Drosophila) | | | | | | Tissue enhanced |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ELL3 | Elongation factor RNA polymerase II-like 3 | | | | | | Tissue enhanced |
EN1 | Engrailed homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EXO1 | Exonuclease 1 | | | | | | Tissue enhanced |
FAM9C | Family with sequence similarity 9, member C | Predicted membrane proteins
| | | | | Tissue enriched |
FBXO5 | F-box protein 5 | | | | | | Tissue enhanced |
FCAR | Fc fragment of IgA, receptor for | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCRLA | Fc receptor-like A | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FUT4 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | Predicted membrane proteins
| | | | | Tissue enriched |
FYB | FYN binding protein | | | | | | Tissue enhanced |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
GBP5 | Guanylate binding protein 5 | | | | | | Tissue enhanced |
GFI1 | Growth factor independent 1 transcription repressor | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GLT1D1 | Glycosyltransferase 1 domain containing 1 | | | | | | Tissue enhanced |
GNLY | Granulysin | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |